220 related articles for article (PubMed ID: 17194167)
1. Can we ensure the safe use of known human teratogens?: The iPLEDGE test case.
Honein MA; Lindstrom JA; Kweder SL
Drug Saf; 2007; 30(1):5-15. PubMed ID: 17194167
[TBL] [Abstract][Full Text] [Related]
2. Isotretinoin: update on controversial issues.
Prevost N; English JC
J Pediatr Adolesc Gynecol; 2013 Oct; 26(5):290-3. PubMed ID: 24147278
[TBL] [Abstract][Full Text] [Related]
3. Circumventing iPLEDGE: Circumventing ethical responsibility?
Lee KC; Bercovitch L
J Am Acad Dermatol; 2017 Dec; 77(6):1185-1187. PubMed ID: 29132856
[No Abstract] [Full Text] [Related]
4. The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system.
Shin J; Cheetham TC; Wong L; Niu F; Kass E; Yoshinaga MA; Sorel M; McCombs JS; Sidney S
J Am Acad Dermatol; 2011 Dec; 65(6):1117-25. PubMed ID: 21565419
[TBL] [Abstract][Full Text] [Related]
5. Isotretinoin and iPledge: a view of results.
Maloney ME; Stone SP
J Am Acad Dermatol; 2011 Aug; 65(2):418-419. PubMed ID: 21763564
[No Abstract] [Full Text] [Related]
6. A comparative review of the isotretinoin pregnancy risk management programs across four continents.
Kovitwanichkanont T; Driscoll T
Int J Dermatol; 2018 Sep; 57(9):1035-1046. PubMed ID: 29508918
[TBL] [Abstract][Full Text] [Related]
7. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero.
Lowenstein EB; Lowenstein EJ
Clin Dermatol; 2011; 29(6):652-61. PubMed ID: 22014987
[TBL] [Abstract][Full Text] [Related]
8. Administrative Burden of iPLEDGE Deters Isotretinoin Prescriptions: Results From a Survey of Dermatologists.
Lee G; Wolf JR; Somers KE
Cutis; 2022 Jul; 110(1):44-47. PubMed ID: 36179224
[TBL] [Abstract][Full Text] [Related]
9. Contraceptive counseling for iPLEDGE and its burden on dermatologists.
Owens KE; Jiang SW; Nicholas MW
Arch Dermatol Res; 2024 May; 316(6):287. PubMed ID: 38805059
[TBL] [Abstract][Full Text] [Related]
10. Does the teratogenicity of isotretinoin outweigh its benefits?
Jordan AY; Parks L; Chen SC; Higgins K; Fleischer AB; Feldman SR
J Dermatolog Treat; 2005; 16(4):190-2. PubMed ID: 16249139
[No Abstract] [Full Text] [Related]
11. We Pledge to Change iPLEDGE.
Pierson JC; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
[No Abstract] [Full Text] [Related]
12. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
Mobacken H; Sundström A; Vahlquist A
Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
[No Abstract] [Full Text] [Related]
13. Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era.
Charrow A; Xia FD; Lu J; Waul M; Joyce C; Mostaghimi A
PLoS One; 2019; 14(3):e0210445. PubMed ID: 30913210
[TBL] [Abstract][Full Text] [Related]
14. The power of Accutane. The benefits and risks of a breakthrough acne drug.
Meadows M
FDA Consum; 2001; 35(2):18-23. PubMed ID: 11444244
[No Abstract] [Full Text] [Related]
15. Isotretinoin: controversies, facts, and recommendations.
Bauer LB; Ornelas JN; Elston DM; Alikhan A
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
[TBL] [Abstract][Full Text] [Related]
16. Isotretinoin for acne and rosacea.
Watson KD; Miest RY; Tollefson MM
Semin Cutan Med Surg; 2016 Jun; 35(2):79-86. PubMed ID: 27416313
[TBL] [Abstract][Full Text] [Related]
17. Eruptive milia during isotretinoin therapy.
Farmer W; Cheng K; Marathe K
Pediatr Dermatol; 2017 Nov; 34(6):728-729. PubMed ID: 28940619
[TBL] [Abstract][Full Text] [Related]
18. Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.
Stobaugh DJ; Deepak P; Ehrenpreis ED
Eur J Clin Pharmacol; 2013 Apr; 69(4):1041-2. PubMed ID: 23052415
[No Abstract] [Full Text] [Related]
19. Advice on the safe introduction and continued use of isotretinoin in acne in the U.K. 2010.
Goodfield MJ; Cox NH; Bowser A; McMillan JC; Millard LG; Simpson NB; Ormerod AD
Br J Dermatol; 2010 Jun; 162(6):1172-9. PubMed ID: 21250961
[No Abstract] [Full Text] [Related]
20. Myths of isotretinoin therapy in patients with acne: a personal opinion.
Alcalay J
J Drugs Dermatol; 2004; 3(2):179-82. PubMed ID: 15098974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
